John Simmons
4Patents
1h-index
9Co-inventors
33Inventor score
Filing activity: Nov 12, 2012 → Mar 30, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9670549B2 | Gene expression signatures of neoplasm responsiveness to therapy | Emerging Cross-Sectional Technologies | 2 | Active |
| US10604499B2 | MYC G-quadruplex stabilizing small molecules and their use | Chemistry; Metallurgy | 0 | Active |
| US11014902B2 | MYC G-quadruplex stabilizing small molecules and their use | Chemistry; Metallurgy | 0 | Active |
| US10196372B2 | MYC G-quadruplex stabilizing small molecules and their use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.